DocuSign’s Life Sciences Module helps pharmaceutical, biotech, and medical tech organizations streamline agreement workflows while maintaining compliance with global regulations like 21 CFR Part 11 and Annex 11. It includes compliant eSignature, automated validation, and SMS-based signer authentication. The module reduces manual errors, improves visibility, and ensures secure, audit-ready processes. It supports digital transformation across drug development, clinical trials, manufacturing, sales, and compliance. Preconfigured account settings, secure storage, and monthly QA reports simplify validation and enhance regulatory readiness, accelerating innovation while safeguarding patient and partner data.

Join for free to read